We are live on ! Find out more
SER icon

Serina Therapeutics
SER

31 hedge funds and large institutions have $2.67M invested in Serina Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

0% more funds holding

Funds holding: 31 → 31 (0)

0% less ownership

Funds ownership: 0.36% → 0.36% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

3% less capital invested

Capital invested by funds: $2.75M → $2.67M (-$87K)

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
2
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$13.2K
2
TRCT
Tower Research Capital (TRC)
New York
+$1.54K
3
SPC
Sigma Planning Corp
Michigan
+$339
4
TCOV
Trust Company of Vermont
Vermont
+$68

Top Sellers

Rank Fund Capital Flow
1
SWIG
Strategic Wealth Investment Group
Kentucky
-$15.4K
2
TSS
Two Sigma Securities
New York
-$6K
3
BlackRock
BlackRock
New York
-$4.66K
4
Millennium Management
Millennium Management
New York
-$4.66K
5
Citadel Advisors
Citadel Advisors
Florida
-$3.85K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadwood Capital
New York
$1.68M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$393K – – –
PGP
3
Prescott General Partners
Florida
$104K – – –
BCM
4
Bridgeway Capital Management
Texas
$95K – – –
BlackRock
5
BlackRock
New York
$74K -$4.66K -206 -5%
SPC
6
Sigma Planning Corp
Michigan
$66K +$339 +15 +0.5%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$56K – – –
SWIG
8
Strategic Wealth Investment Group
Kentucky
$46K -$15.4K -683 -23%
Creative Planning
9
Creative Planning
Kansas
$41K – – –
SXL
10
Summit X LLC
Missouri
$18K -$317 -14 -1%
Northern Trust
11
Northern Trust
Illinois
$18K – – –
State Street
12
State Street
Massachusetts
$15K – – –
VF
13
Virtu Financial
New York
$12K +$13.2K +585 New
Millennium Management
14
Millennium Management
New York
$10K -$4.66K -206 -30%
BWCS
15
Beirne Wealth Consulting Services
Connecticut
$10K – – –
LPL Financial
16
LPL Financial
California
$7K -$158 -7 -2%
TRCT
17
Tower Research Capital (TRC)
New York
$7K +$1.54K +68 +25%
Citadel Advisors
18
Citadel Advisors
Florida
$6K -$3.85K -170 -37%
Osaic Holdings
19
Osaic Holdings
Arizona
$2K – – –
CC
20
Corsicana & Co
Texas
$1K – – –
PSB
21
Piscataqua Savings Bank
New Hampshire
$1K – – –
RAM
22
Riggs Asset Management
Pennsylvania
$1K – – –
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$188 – – –
TSS
24
Two Sigma Securities
New York
– -$6K -309 Closed
Bank of America
25
Bank of America
North Carolina
– -$633 -28 -82%
1
2

SER Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q3 2022, worth a combined $2.67M — down 3.2% from $2.75M a quarter earlier.

Fund positioning in SER was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 8 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $13.2K. The largest seller was Strategic Wealth Investment Group, cutting an estimated $15.4K.

  • 31 institutional investors held Serina Therapeutics (SER) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $2.67M of Serina Therapeutics stock for Q3 2022, down 3.2% quarter-over-quarter.
  • 2 funds opened new Serina Therapeutics positions in Q3 2022 and 2 closed out, a net change of 0 holders.
  • The largest Serina Therapeutics buyer in Q3 2022 was Virtu Financial, an estimated $13.2K added.
  • The largest Serina Therapeutics seller in Q3 2022 was Strategic Wealth Investment Group, an estimated $15.4K sold.

Based on aggregated 13F filings for Q3 2022.